Bruker Corporation (BRKR)
Bruker Corporation is a NASDAQ-listed common equity of a healthcare-sector company that develops, manufactures, and distributes scientific instruments as well as analytical and diagnostic solutions. Through its four reporting segments — BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & SuperCon Technologies — the company serves a range of research, laboratory, and industrial applications. Its portfolio includes magnetic resonance spectroscopy systems, preclinical imaging, NMR and EPR products, life science tools, mass spectrometry solutions, diagnostic kits, microscopy and X-ray instruments, and products used in lab automation, digitalization, and process analysis. Bruker also provides superconducting materials and related high-technology tools. Founded in 1960, the company is headquartered in Billerica, Massachusetts.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-BRKR
|
$51.91
|
-12.9% Downside
|
Fair
|
$59.75
|
0.3% Upside
|
Fair
|
Fair
|
—
|
—
|
0.2
|
0.4%
|
August 5, 2026
|
-248.5x
|
3.7x
|
2.6x
|
8.551 B
|
10.671 B
|
16.5%
|
68.0%
|
3.7
|
-377.6%
|
-140.9%
|
